Image for illustrative purposes only. Not a real photo.

MetaVia presents new late-breaking obesity and metabolic data at ADA 2026

Written by Mahathir BayenaPublished Jun 8, 2026, 12:57 PM

MetaVia (NASDAQ:MTVA) has reported new data from its cardiometabolic pipeline at the American Diabetes Association’s (ADA) 2026 Scientific Sessions in New Orleans.

More ways to discover

Browse United States news Discover NYSE signals Browse all NYSE stocks Browse all NYSE ETFs Explore United States companies Find the right NYSE index

More ways to discover

Assets related to this article